Hildebrand Laura, Gaber Timo, Kühnen Peter, Morhart Rolf, Unterbörsch Heinz, Schomburg Lutz, Seemann Petra
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Germany.
Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Germany.
J Trace Elem Med Biol. 2017 Jan;39:186-192. doi: 10.1016/j.jtemb.2016.10.001. Epub 2016 Oct 4.
Fibrodysplasia Ossificans Progressiva (FOP) is a rare inherited disease characterized by progressive heterotopic ossification. Disease onset, severity and symptoms vary between FOP patients, as does the frequency and activity of so-called flare-ups, during which tendons, ligaments, muscle and soft tissue are replaced by bone. Traumata, infections or other stressors are known inducers of flare-ups, and the hormone Activin A may be involved in disease activity; however, reliable biomarkers for FOP activity are missing, and the basal trace element and inflammatory state of patients are unknown. We hypothesized that FOP patients develop characteristic deficiencies in inflammation-related trace elements and display a chronically increased inflammatory cytokine level, collectively aggravating disease course and flare-up risk. Serum samples from 15 FOP patients and 25 relatives were collected under highest quality standards. Concentrations of Cu, Se and Zn were determined by total reflection X-ray fluorescence, and 27 cytokines along with Activin A by specific antibody-based techniques. Data were tested for normal distribution and analyzed by parametric or non-parametric tests. Concentrations of Se and Cu were not different between the groups, while Zn levels were slightly higher in FOP as compared to controls (1110±251 vs. 970±176ng/ml, P=0.04). The average concentrations of cytokines and Activin A were not different. When focusing on the two patients with self-reported flare-ups, again no obvious differences were noted. The cytokines Eotaxin, G-CSF, hbFGF and TNF-α were within the upper half of measured concentrations, and may warrant further longitudinal analyses. Our data do not support the hypothesis that FOP patients display a characteristic pattern of trace elements or have a generally increased tone of pro-inflammatory cytokines.
进行性骨化性纤维发育不良(FOP)是一种罕见的遗传性疾病,其特征为进行性异位骨化。FOP患者的发病时间、严重程度和症状各不相同,所谓的病情发作频率和活动情况也是如此,在此期间肌腱、韧带、肌肉和软组织会被骨组织替代。创伤、感染或其他应激源是已知的病情发作诱因,激活素A激素可能参与疾病活动;然而,目前缺乏用于评估FOP疾病活动的可靠生物标志物,患者的基础微量元素和炎症状态也尚不明确。我们推测,FOP患者在与炎症相关的微量元素方面存在特征性缺乏,且炎症细胞因子水平长期升高,这些因素共同加剧了疾病进程和病情发作风险。我们按照最高质量标准采集了15例FOP患者和25名亲属的血清样本。通过全反射X射线荧光法测定铜、硒和锌的浓度,采用基于特异性抗体的技术测定27种细胞因子以及激活素A的浓度。对数据进行正态分布检验,并通过参数检验或非参数检验进行分析。两组之间硒和铜的浓度没有差异,而FOP患者的锌水平略高于对照组(1110±251对970±176ng/ml,P=0.04)。细胞因子和激活素A的平均浓度没有差异。聚焦于两名自述有病情发作的患者时,同样未发现明显差异。嗜酸性粒细胞趋化因子、粒细胞集落刺激因子、人碱性成纤维细胞生长因子和肿瘤坏死因子-α的浓度处于所测浓度的上半部分,可能需要进一步进行纵向分析。我们的数据不支持FOP患者存在微量元素特征性模式或促炎细胞因子总体水平升高这一假设。